SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-010927
Filing Date
2020-09-01
Accepted
2020-09-01 08:28:33
Documents
14
Period of Report
2020-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20200901x8k.htm   iXBRL 8-K 49814
2 EX-10.1 bpmc-20200901xex10d1.htm EX-10.1 95248
3 EX-99.1 bpmc-20200901xex99d1.htm EX-99.1 16249
  Complete submission text file 0001558370-20-010927.txt   309522

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpmc-20200901.xsd EX-101.SCH 3239
5 EX-101.LAB bpmc-20200901_lab.xml EX-101.LAB 15499
6 EX-101.PRE bpmc-20200901_pre.xml EX-101.PRE 10528
7 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20200901x8k_htm.xml XML 4633
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 201153343
SIC: 2834 Pharmaceutical Preparations